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1. Introduction  
The liver is the second largest organ in the body after the skin and has important storage, 
detoxification and synthetic functions. Liver diseases encompass a multitude of pathologies 
and the management of these diseases involves diagnostic and therapeutic investigations 
and interventions; some of which are invasive. Histological assessment  of the liver and 
lesions within  via liver biopsies are an important tool in the armamentarium of invasive 
investigations for liver diseases of both a surgical and non-surgical nature. 
Liver biopsy has been used for over 100 years  in the assessment of liver diseases (Valori and 
Elias 1989). Paul Ehrlich performed one of the first percutaneous liver biopsies in the late 
19th century in Germany to assess glycogen levels in the liver of a diabetic patient (Grant 
and Neuberger 1999). However, the procedure did not really gain popularity until Menghini 
refined the technique in the mid 20th century(Menghini 1958). In the last fifty years the 
techniques for liver biopsy has been continuously refined and although today there are 
several biochemical and imaging techniques to assess liver disease biopsy remains 
important in assessment. Today, widespread application allows for blind, open and image 
guided liver biopsies, although ultrasound guided biopsies are considered superior 
(Younossi, Teran, Ganiats and Carey 1998). Image guided percutaneous liver biopsies 
remains the mainstay of this procedure while open biopsies may be undertaken as an 
adjunct to laparoscopic or other open surgical procedures. There are presently various 
techniques and equipment for percutaneous liver biopsies and this procedure is performed 
by both gastroenterologists/hepatologists and radiologists. The choice of technique and 
equipment is however operator dependent. 
2. Indication    
In the past the indications for liver biopsies and the practice thereof varied significantly 
between institutions. This was born out in an audit conducted by the British society of 
Gastroenterology and the Royal College of Physicians of London (Gilmore, et al. 1995). 
Subsequent to this the British Society of Gastroenterology published guidelines on the use of 
liver biopsy in an attempt to standardize indications and technique for this procedure 
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(Grant, et al. 1999). Similar guidelines have since been published by the American 
Association for the Study of Liver Diseases (Rockey, Caldwell, Goodman, Nelson and Smith 
2009). These indications are beyond the remit of this chapter and can be sourced from the 
guidelines.  
3. Methods   
There are various methods for performing liver biopsies. In the main most liver biopsies 
are performed percutaneously. In the UK this method is performed by radiologists under 
image guidance. In support of image guided biopsies  Vautier et al suggests that the ideal 
liver biopsy is one that is performed under ultrasonic guidance (Vautier, Scott and Jenkins 
1994). However there are still some clinicians who practice liver biopsies without image 
guidance. In a survey conducted by Muir et al about current practice of liver biopsy 53.2% 
of clinicians still performed liver biopsies without image guidance (Muir and Trotter 
2002). Guided liver biopsies are undertaken with real time imaging  using ultrasound or 
CT scans. Real time imaging allows for accurate biopsy of lesions and avoidance of major 
vascular, biliary or bowel structures and thus reduce the incidence of complications.  This 
can be via the transthoracic or the subcostal route and may be plugged or unplugged. 
Plugged percutaneous liver biopsies involves the injection of a gelatin substance into the 
biopsy cavity after withdrawal of the specimen. It reduces the complication of bleeding 
and can be used in patients with impaired coagulation (Fandrich, Davies and Hall 1996). 
In patients with coagulopathy in whom a percutaneous biopsy is considered 
inappropriate a transvenous (transjugular or transfemoral) approach can be used (Lebrec, 
Goldfarb, Degott, Rueff and Benhamou 1982, Sawyerr, et al. 1993).  Laparoscopic liver 
biopsy is used in centres where expertise in the transvenous approach is unavailable for 
patients with a bleeding coagulopathy. A general anaesthetic is necessary where the 
laparoscopic approach is contemplated. In many instances it is undertaken when a liver 
lesion is found incidentally during diagnostic or staging laparoscopy. It can also be used 
in assessing the degree of cirrhosis of the future liver remnant in patients who are 
undergoing staging laparoscopy for consideration of liver resection for hepatocellular 
carcinoma. Laparoscopic liver biopsy allows direct visualisation of the area to be biopsied 
and immediate control of any haemorrhage. The complications of this procedure includes 
those associated with the anaesthesia, the laparoscopy and the biopsy. In our institution, 
we believe that all percutaneous liver biopsies should be image guided. As a 
result of the associated risks our patients are admitted for post biopsy 
observation for 6 hours as per the British society of Gastroenterology and the 
American Gastroenterological Association guidelines(Grant, et al. 1999, Rockey, 
et al. 2009). In other centres in the USA percutaneous liver biopsy is performed as 
an outpatient procedure with one of the stipulations being the patient is able to 
return to the hospital within 30 minutes if symptoms of a complication 
develop(Jacobs and Goldberg 1989). 
4. Complications      
The complications of liver biopsy can be divided into those in the immediate, early or late 
period (Table 1).  The overall reported complication rate varies significantly (Galati, et al. 
1994, Gilmore, et al. 1995, Grant, et al. 1999).  These can range from minor complications 
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such as pain and transient hypotension to major complications such as visceral perforation 
or significant bleeding which may lead to death. The incidence of major complications was 
reported to be as high as 4% with a mortality rate ranging from 0.01% to 0.33%(McGill, 
Rakela, Zinsmeister and Ott 1990). Differences in complication rate has been reported 
between blind and ultrasound guided liver biopsies with ultrasound guided biopsies 
proving superior for both accuracy and risk of complications(Riley 1999, Al Knawy and 
Shiffman 2007).  
 
Immediate Early(within 24 hours) Late 
Death Death 
Needle tract seeding of Tumour 
cells 
Pain Pain Biliary fistula 
Bleeding Bleeding Septicaemia 
Septicaemia Septicaemia Biloma 
Perforation of  nearby 
organs 
Biliary peritonitis Pleural effusion 
Pneumothorax 
Haemothorax 
Haemobilia Intrahepatic arterio-venous fistula 
Needle fracture   
Table1. Complications of Liver Biopsy 
In addition, it is well documented that the risk of complications increases with the increase in 
the number of needle passes necessary for sampling(McGill, et al. 1990). Blind biopsies require 
more needle passes than ultrasound guided biopsies and have been statistically proven to 
increase the risk of complications(Cadranel, Rufat and Degos 2000, Mayoral and Lewis 2001).  
The issue of the relationship of needle size or type to complication rate remains controversial. 
McGill et al compared  a 1.6mm diameter needle to a 1.9mm needle and found no difference in 
the incidence of  of haematomas(McGill, et al. 1990). The same is true for the study by Forsell 
et al (Forssell, Bonkowsky, Anderson and Howell 1981). However prior to this, the multicentre 
retrospective study conducted by Piccinino suggested a higher incidence of bleeding with 
cutting type needles (Piccinino, Sagnelli, Pasquale and Giusti 1986). 
Finally, as with most invasive procedures the most significant factor in the incidence of 
complications associated with liver biopsy is operator experience. In the nationwide survey 
conducted in Switzerland on the practice and complications of liver biopsy Froelich et al 
reported  that no complications occurred with internists performing more than 50 biopsies a 
year but a 1.68% complication rate with internists performing less than 12 biopsies a year 
(Froehlich, Lamy, Fried and Gonvers 1993). The national audit of percutaneous liver biopsy 
conducted in England and Wales confirms Froelich’s findings.  It was found that the 
frequency of complications was 3.2% for biopsies performed by operators with less than 20 
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previous biopsy procedures. In contrast, it was only 1.1% when performed by those who 
had conducted more than 100 biopsies(Gilmore, et al. 1995).   
From the large retrospective study conducted by Piccinino it was reported that 61% of 
complications occurred within the first 2 hours after biopsy and 96% in the first 24 hours 
(Piccinino, et al. 1986). Arturo et al suggests that up to 3% of patients may require 
hospitalization for complications of liver biopsy, more so if the procedure is performed with 
a tru-cut needle(Bravo, Sheth and Chopra 2001). For the purpose of this chapter we are 
going to focus on the complications associated with percutaneous liver biopsy as this is the 
commonest method in use. The specific complications associated with other methods will be 
briefly discussed at the end.  
4.1 Mortality 
Liver biopsy associated mortality is reportedly related to haemorrhage or biliary peritonitis 
(Vautier, et al. 1994, Shah, Mayberry, Wicks, Rees and Playford 1999). The reported 
incidence of mortality varies (Grant, et al. 1999) and to date the true incidence is not known. 
Three month post biopsy mortality rate is reported to be as high as 19%(Gilmore, et al. 
1995).  This is probably a result of the primary indication for the liver biopsy; i.e. liver failure 
and malignancy and not necessarily a result of the biopsy itself. Although logic would 
suggest that image guided biopsy would result in a statistically lower mortality rate 
compared to blind biopsies, this has actually never been born out in published reports.  
Griffiths et al(Griffiths, Viiala and Olynyk 2002) and others  reported the mortality 
associated with liver biopsies to range from 0.01% to 0.1%(Piccinino, et al. 1986, McGill, et al. 
1990). However, this is for both blind and guided biopsy.  
Other authors have also refuted the claim that image guided biopsies reduces mortality rates. 
Centinkaya et al published a retrospective study of  205 patients who had either blind or  
guided biopsies of the liver and no difference was found in the incidence of mortality(0% in 
each group) (Züleyha Akkan Çetinkaya 2010).  Indeed, most of the published data on 
mortality is from retrospective studies. In 1991 the national audit undertaken in England and 
Wales looked at the outcome of 1504 liver biopsies. Two patients died as a result of blind 
biopsy whereas there were no directly related deaths in the image guided cohort. This was  
not statistically significant however(Gilmore, et al. 1995). In 2010 West and Card published an 
epidemiological study on the mortality rates in elective percutaneous liver biopsy(West and 
Card 2010). Again this was a study based on restrospective data analysis. In it the all  
cause seven day mortality was 0.2% but mortality directly related to liver biopsy was 1 in 
10,000. 
In effect, the true incidence of biopsy related mortality and the effect of image guidance on 
the incidence of mortality is not known. Vautier et al(Vautier, et al. 1994) suggested that a 
large study involving an estimated 10,000 patients would be needed to demonstrate any 
statistical difference.   
4.2 Pain 
Pain is the most common complication after percutaneous liver biopsy. The incidence  
of pain during liver biopsy is reported to be as high as 84%(Eisenberg, et al. 2003).  This 
pain can be acute and can last for more than 24 hours after the procedure(Castera, Negre, 
Samii and Buffet 1999). Eisenberg et al reported that 40% of patients in their prospective 
study experienced pain 24 hours after the procedure. Indeed, if the pain is due to hepatic 
friction rub the pain may last for a few weeks (Chuah 1996).  The intensity of this pain is 
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mainly mild to moderate(Farrell, et al. 1999, Cadranel, et al. 2000) but can be severe.  
In a study conducted by Christine Janes in 1993, of the four hundred and five patients 
who had liver biopsies as outpatients, five of the thirteen patients (1.2%) requiring  
post-procedure hospitalization was as a result of pain(Janes and Lindor 1993).  A similar 
figure of 1.2% was quoted for the experience of severe pain by Christopher Pokorny in  
his study of radiologically guided liver biopsy, however none of these patients were 
admitted to hospital(Pokorny and Waterland 2002).   The pain can be localized to the site 
of the biopsy or commonly be referred to the right shoulder tip. There is also a distinct  
sex difference in the experience of pain. The intensity of pain is reportedly higher in 
women although the cause of this is unknown (Cadranel, et al. 2000). In addition, 
Eisenberg et al demonstrated that there was a linear correlation between the level of  
pre-biopsy anxiety and the intensity of the experienced pain.  It is possible that there is a 
positive correlation between levels of anxiety and gender but this has yet to be assessed 
and reported.  
The etiology of post liver biopsy pain is thought to be multi-modal. Pain can indicate post 
biopsy peritoneal irritation if bleeding or peritoneal soiling from biliary leakage of visceral 
perforation occurs.  However, pain at the biopsy site may emanate from stimulation of 
nocioceptive fibres in the skin and liver capsule. In contrast, shoulder tip pain may be 
viscerosomatic in origin(Hederstrom, Forsberg, Floren and Prytz 1989). The use of 
ultrasound guided biopsy has been reported to decrease the incidence of post biopsy pain. 
In the study conducted by Lindor et al nine patients required post biopsy hospitalization 
when ultrasound was not used compared to two patients in the biopsy under ultrasound 
guidance group. More importantly, of the nine patients, seven were hospitalized for 
pain(Lindor, et al. 1996). This view is supported by the review of the literature on blind 
versus ultrasound guided biopsy by Knawy et al. They found that ultrasound guidance 
resulted in a 10.9%  decrease in biopsy pain (P<0.0001)  and a decrease in pain related 
morbidity (1.8% vs 7.7%) (Al Knawy, et al. 2007). 
Interestingly, both local anaesthetic with or without conscious sedation has been used in an 
attempt to control pain and in spite of this pain continues to be the commonest complication 
of liver biopsy. Conscious sedation has however shown some promise in reducing pain 
during and after liver biopsy. It is also possible that the administration of anxiolytics pre-
biopsy may alleviate some of the pain experienced. Despite pain being a significant issue 
there is no published data on the optimization of pain control in patients undergoing liver 
biopsy.   
4.3 Bleeding 
Bleeding after percutaneous liver biopsy is a well documented complication second only  
to pain(Chuah 1996). This can be minor or be significant enough to warrant intervention.  
The reported incidence of bleeding varies significantly (Piccinino, et al. 1986, Chuah, Moody, 
Wicks and Mayberry 1994, Thampanitchawong and Piratvisuth 1999) and is the main cause  
of mortality after biopsy(Froehlich, et al. 1993). McGill reports it to be between 2%-4% in  
their 21 year experience with a mortality rate of 0.01%-0.03%(McGill, et al. 1990). The 
admission of those with bleeding is about 0.2%. The fatalities are usually due to inadvertent 
perforation of the hepatic or portal vein or aberrant hepatic artery. It may also result from a 
laceration in the liver if the biopsy needle is intrahepatic while the patient inhales 
deeply(Chuah 1996). 
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The risk is reportedly increased with the presence of ascites (Grant, et al. 1999) probably as a 
result of the dilutional effect of the ascitic fluid on clotting factors however the incidence is 
not affected by the use of ultrasound (Stone and Mayberry 1996). Like the use of ultrasound, 
the risk of haemorrhage is not related to needle diameter or type (Froehlich, et al. 1993). 
However, the relationship between coagulopathy and bleeding remains controversial. In the 
United States the conventional approach is to withhold percutaneous biopsy if the INR is 
greater than 1.5 (Rockey, et al. 2009). The survey conducted by Chuah et al suggested that 
coagulopathy should be corrected prior to biopsy (Chuah, et al. 1994). This is supported by 
other studies. Caldwell et al reviewed 2740 percutaneous liver biopsies in patients with 
hepatitis C. They recorded 16 out of 29 adverse events caused by severe bleeding. 
Statistically, the factors that were associated with increased bleeding included a platelet 
count of less than 60,000, INR greater than 1.3, the presence of varices and low albumin 
(Caldwell and Northup 2010). They suggested that the increase in bleeding with low 
albumin and varices is likely to be due to the changes in hepatic vasculature and not a 
clotting abnormality.  
Although one other study has corroborated the cut off value of platelet count as 60,000 
(Sharma, McDonald and Banaji 1982) there are other studies that suggest otherwise. 
Sherlock et al reports a cut off platelet count of 80,000 and Sue et al a cut off count of 50,000 
(Grant, et al. 1999). In the retrospective study conducted by Pornpen et al they found that 
coagulopathy was related to bleeding complications and death (Thampanitchawong, et al. 
1999). The bleeding complication rate increased from 3.6% to 10.5% and the death rate 
increased from 1% to 7% when the thrombin time increased by greater than 3 seconds over 
control and the prothrombin time increased by more than 10 seconds over control. The  
same was true for patients with a platelet count of greater than 70,000. However,  
platelet count was the only independent variable on logistic regression analysis.  
In effect, the absolute cut off point is unknown. In addition to this it is thought that platelet 
function also plays a more important role in the risk of bleeding after biopsy than platelet 
number (Tripodi, et al. 2006).  Other risk factors include multiple passes with the biopsy 
needle, the presence of cirrhosis (Janes, et al. 1993) and the use of cutting needles (Piccinino, 
et al. 1986).  
In contrast, Ewe et al and others demonstrated no effect of bleeding abnormalities on the 
risk of bleeding with either laparoscopic or percutaneous liver biopsy (Ewe 1981, McVay 
and Toy 1990, Dillon, Simpson and Hayes 1994).  Even in Caldwell’s study three of the 
patients with haemorrhagic complications after biopsy had a platelet count of over 150,000.  
Finally, the question of ultrasound reducing the risk of haemorrhage remains unanswered. 
Several studies have demonstrated that ultrasound reduces the incidence of complications, 
none of these studies reported any specific difference in haemorrhage(Lindor, et al. 1996, 
Stone, et al. 1996, Manolakopoulos, et al. 2007). In our unit, we accept a platelet count of 
greater than 80,000 and an INR of less than 1.5 in order to proceed to biopsy.  
The haemorrhage associated with percutaneous liver biopsy can present as intraperitoneal 
bleeding, intrahepatic bleeding, haemobilia and subcapsular haematoma(Figure 1) (Caldwell, 
et al. 2010).  Intraperitoneal bleeding although rare, when clinically significant generally 
becomes apparent within the first 2-3 hours after biopsy(Van Thiel, Gavaler, Wright and 
Tzakis 1993) and is usually heralded by a drop in haemoglobin of greater than 2g/dL or 
haemodynamic instability(Knauer 1978).  If intraperitoneal haemorrhage is suspected the 
patient should be resuscitated, have imaging studies (CT or ultrasound) to confirm this and if 
resuscitation fails then angiography and embolisation or less commonly surgery to halt 
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bleeding. Intrahepatic or subcapsular haematomas tend to be asymptomatic(Raines, Van 
Heertum and Johnson 1974) and occurs in about 23% of patients(Minuk, Sutherland, Wiseman, 
MacDonald and Ding 1987). However, large haematomas can present with pain or signs of 
intravascular depletion i.e hypotension and tachycardia(Van Thiel, et al. 1993). In the main 
these haematomas can be treated conservatively with resuscitation and correction of 
coagulopathy or thrombocytopenia if it exists. 
 
 
 
Fig. 1. This patient with hepatitis C became haemodynamically unstable following a 
percutaneous liver biopsy. A superselective angiogram of the liver shows a subcapsular 
bleed, which was embolized with microcoils (red arrows).  
Although post biopsy haemorrhage  usually presents itself within the fist 2-3 hours there 
have been reports of delayed bleeding (Reichert, Weisenthal and Klein 1983). Yeo et al 
described a case of a patient who was hepatitis C positive with haemophilia who presented 
10 days after an image guided percutaneous liver biopsy(Yeo, Tan, Dan and Wai 2008). He 
presented to the emergency department complaining of hypochondrial pain and 
investigations demonstrated a haemothorax and subcapsular haematoma. He 
decompensated and had an emergency resuscitative thoracotomy.  In another case a 46 year 
old gentleman who represented 4 days after percutaneous biopsy with right hypochondrial 
pain. He was diagnosed with a bleeding pseudoaneurysm of the right hepatic artery which 
was embolised. Subsequently, he continued to bleed and had a laparotomy which 
demonstrated a right hepatic lobe laceration (Ren, Piao and Jin 2006). Although this is very 
rare there have been other reports of post biopsy pseudoaneurysm formation(Figure 2 a & 
b)(Kowdley, Aggarwal and Sachs 1994, Own, Balzer and Vogl 2005). Surprisingly, Terjung 
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et al reported the incidence of delayed bleeding in their series to be 70%(Terjung, et al. 2003). 
In their series they defined delayed bleeding as occurring after 24 hours. This is a 
particularly high incidence and it may well reflect the definition criteria or the enthusiasm 
with which patients are investigated for haemorrhage. There may well be a large cohort of 
post biopsy delayed haemorrhage who are asymptomatic and therefore the true incidence is 
not known.   
 
 
 
(a)    (b) 
Fig. 2. (a & b) CT scans on a patient with a past history of a percutaneous liver biopsy 
showing a ruptured pseudoaneurysm with active bleeding.   
Haemobilia is a rare complication of liver biopsy and was first reported by in 1967 by Cox 
(Cox 1967).  In 1991 Merrell and Schneider described the evolution of haemobilia and 
suggested a lag time between biopsy and presentation to be about 5 days. Interestingly, 
haemobilia after biopsy has been associated with acute pancreatitis(Pena, Horn and Cross 
2009). It is thought that the pancreatitis is induced in the same manner as gallstones; 
impairment of pancreatic drainage. The treatment required is ERCP and sphincterotomy. 
Angiography has also been used to stem the bleeding but only in a few cases.  
4.4 Septicaemia 
Septicaemia is a result of bacteraemia during needle biopsy. It can also result from the 
development of intrahepatic abscesses (Figure 3). The incidence of bacteraemia is reported to 
be as high as 13 % (McCloskey, Gold and Weser 1973, Le Frock, Ellis, Turchik, Zawacki and 
Weinstein 1975). However more commonly the figure is quoted to be less than 1% (Larson, et 
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al. 1997). It is more common in patients with biliary abnormalities including biliary 
obstruction, cholangitis and those who have had biliary bypass(Bubak, Porayko, Krom and 
Wiesner 1991, Larson, et al. 1997, Bravo, et al. 2001). However, one of these studies was in 
patients who had liver transplant and therefore may be immunosuppressed and at higher risk 
of infections.  McCloskey et al reported an incidence of liver biopsy related septicaemia of 
2.9%. They suggested that in patients with liver disease there is a defect in the defence 
mechanisms related to a deficiency of complement and inhibition of chemotaxis among others 
(McCloskey, et al. 1973). In those with septicaemia the commonest organism cultured from the 
blood is E. Coli (Moreira Vicente, Hernandez Ranz, Ruiz Del Arbol and Bouza 1981) although 
polymicrobial organism infection has been reported (Dhawan, Thadepalli, Ulmer and Akhtar 
1983) including klebsiella and streptococcus. 
 
 
 
Fig. 3. This patient presented with right upper quadrant pain and pyrexia 4 days following a 
percutaneous liver biopsy. Note the liver mass associated with air within and surrounding 
the mass. The patient was treated for a liver abscess. Note echogenic contents within the 
pleural sac indicative of blood or pus (arrow).     
Although bacteraemia with or without septicaemia is a rare but recognized complication of 
liver biopsy the question of whether prophylactic antibiotics is warranted remains 
unanswered. This is mainly because there are no randomized trials examining this and most 
of the reported data are either case reports or retrospective studies. It is probably 
worthwhile in patients who are immunocompromised (e.g transplant patients). It would be 
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considered prudent to delay this invasive procedure if possible in patients who have 
confirmed sepsis. In addition, patients with obstructive jaundice or who are considered at 
risk should also probably have prophylactic antibiotics. 
4.5 Pulmonary complications 
The transthoracic approach traverses the pleural space. The incidence of complications 
was reported to be 25% in the Swiss survey (Froehlich, et al. 1993). Hydrothorax occurs as 
a result of leakage of ascitic fluid via the biopsy tract into the pleural cavity  
(Zamcheck and Sidman 1953). Pneumothoraces tend to occur in about 0.35% of cases 
(Piccinino, et al. 1986) (Figure 4). In addition, haemothoraces are also possible but rare 
with a reported incidence of 0.018% (Piccinino, et al. 1986). It is thought to be a result of 
injury to the diaphragmatic vessels (Majid 1990) and the event usually declares itself early 
on.  
 
 
B
Liver
 
Fig. 4. Attempted liver biopsy on a 36-year old female with non-specific hepatic dysfunction. 
The needle entered the pleural cavity. Ultrasound examination shows blood in the pleural 
sac (B) at various stages of organization. The diaphragm is marked by a red arrow.  
4.6 Visceral perforation 
Visceral perforation includes puncture of the colon, kidney, lung or gallbladder. Piccinino et 
al reported the incidence of visceral perforation to be between 0.01%-0.1%(Piccinino, et al. 
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1986). This is supported by others (van der Poorten, et al. 2006). These complications can 
resolve with conservative management or can result in peritonitis requiring surgery. 
 
 
K
 
Fig. 5. Attempted liver on a 16 year old with a Riedle’s lobe. The needle has entered the 
kidney (white arrow) the kidney is labelled K. The patient subsequently developed 
intractable haematuria and had to have several blood transfusions.  
4.7 Needle fracture 
Fracture of the needle is a very rare complication. Robert Peters reported a case of a 
Menghini needle fracture during liver biopsy in 1968 leaving the distal end in the patient’s 
chest wall (Peters 1968).  Subsequent to that Purow et al in 1977 and Lazar et al in 1978 
reported this as a complication of liver biopsy (Grant, et al. 1999). It is thought to be a result 
of thrusting the needle onto the rib in the transthoracic  approach.  However, there have 
only been a few reported cases of needle fracture. Indeed,  a search of the literature has not 
resulted in any reported cases in the last decade. This is probably due to the increasing 
expertise in those carrying out liver biopsies and possibly the use of image guidance.  
4.8 Arteriovenous fistula 
Traumatic arteriovenous fistulas in relation to the biliary vasculature has been described as 
early as 1952(Strickler, Lufkin and Rice 1952). The incidence is reported to be as high as 50% 
if an angiogram is performed within one week of the biopsy (Hellekant 1976). A number of 
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other authors have quoted a much lower incidence(Okuda, et al. 1978). This is probably a 
function of the fact that these lesions are not investigated unless the patients are symptomic 
and they tend to resolve spontaneously(Hurwitz and Thompson 2002).  These patients tend 
to present as delayed haemorrhage in the form of frank intraperitoneal haemorrhage with 
shock, intrahepatic haematoma with pain and anaemia or haemobilia (Ormann, Starck and 
Pausch 1991). However, late presentations occur in the form of portal hypertension for 
arterio-portal fistulas and congestive cardia failure in the case of hepatic arteriovenous 
fistulas(Wallace, Medellin and Nelson 1972). The occurrence of fistulas is not isolated to 
percutaneous liver biopsy. Guarkuqi et al described a case of fatal haemobilia after 
transjugular liver biopsy in a patient with alcoholic cirrhosis 1 day after biopsy(Gurakuqi, et 
al. 2008). The haemobilia itself can cause pancreatitis(Machicao, Lukens, Lange and Scolapio 
2002) and may result from an arteriovenous fistula(Cacho, et al. 1996) or a portobiliary or 
arteriobiliary fistula.  Interestingly, arteriovenous fistulas after liver biopsy have been 
described elsewhere. In 1975 Satava et al described a case of an arteriovenous fistula of the 
omentum after liver biopsy. Whatever the presentation of the fistula, the main components 
of treatment is resuscitation, investigation and treatment.  Treatment in the form of 
embolisation is usually successful and if not then surgery with the aim of ligation of the 
arterial component is the next best step.  
4.9 Tumour seeding 
Advances in imaging, operative procedures and chemotherapeutic agents has increased the 
pool of patients suitable for Liver resection of primary and secondary liver cancers and the 
long term survival.  Needle track seeding is well documented in the literature (Davies, 
Tulgan, Parkinson, Goel and Budnitz 1968, Evans, Harries and Hobbs 1987)(Figure 6). This 
has been reported in both biopsies for primary or secondary liver tumours(Park, et al. 1989, 
Smith 1991, Vergara, Marucci, Marcarino, Brunello and Capussotti 1993, Jones, Rees, John, 
Bygrave and Plant 2005). It is thought that needling a tumour could implant up to 100,000 
tumour cells along the tract(Ryd, Hagmar and Eriksson 1983). The occurrence of needle 
track seeding after tumour biopsy is known to result in poorer long term survival(Cresswell, 
Welsh and Rees 2009) and convert a potentially resectable lesion to being unresectable. In 
spite of this there are still reported incidences of patients undergoing biopsy of liver lesions 
before being referred to a specialist unit (Al-Leswas, O'Reilly and Poston 2008). The 
incidence of tumour seeding has been reported to be has high as 19% and in one study 
significantly reduced 4-year survival from 46.7% to 32.5% (Jones, et al. 2005). The same 
holds true for hepatocellular carcinoma.  The meta-analysis and systematic review by Silva 
et al reported a seeding rate 2.7% in biopsy of hepatocellular carcinoma(Silva, et al. 2008). In 
addition, the long term survival is also significantly affected with 5 year survival reported to 
decrease from 52% to 24%(Young, et al. 2007).  
It is clear that modern day practice of surgery dictates that all patients with liver lesions 
should be referred to a specialist centre for investigation and management. The advances in 
MRI, PET and CT along with ultrasound and measurement of tumour markers without 
histology have reported accuracies of over 97% and should provide enough information in 
the majority of cases for management decisions to be made(Torzilli, et al. 2004). The only 
real indication for biopsy of suspicious liver lesions would be in patients who are 
considered to be irresectable by a specialist centre and a histological diagnosis is necessary 
to determine consideration for chemotherapy.  
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Fig. 6. This patient with a colorectal cancer had a small subcapsular lesion shown on a CT. 
At laparoscopy the subcapsular lesion was biopsied, which was positive for a metastasis. 
The patient had a laparotomy 3 weeks latter. The picture shows multiple tiny serosal 
deposits  
4.10 Biliary fistulas 
Biliary fistulas are a rare complication of liver biopsy. They can be divided into intenal or 
external fistulas. Internal fistulas occur between the biliary tree and an adjacent sturcture. 
These include arterio-biliary or bilio-venous fistulas. These patients can present with 
haemobilia or pancreatitis. In one large series percutaneous liver biopsy has been reported 
to cause haemobilia in 4 out of 68,276 patients (Piccinino et al 1986). The reported incidence 
of this is between 0 to 1% (Rossi et al 2002) and can usually be managed by embolisation of 
the vessel. More rarely, biliovenous fistulas can present as bile pulmonary embolism with 
fatal consequences (Brown and Walsh 1952). Fistulas can also develop between the biliary 
tree and an adjacent organ or cavity such as a bronchobiliary or pleurobiliary fistula 
(Ferguson and Thomas 1967). They can present as bilioptysis and can be managed 
conservatively by ERCP to decompress the biliary tree and allow preferential flow of bile 
into the duodenum or, failing that, surgical intervention (Chong et al. 2008). Biliary fistulas 
can also present bilio-cutaneous fistulas (Hatzidakis et al 2006). The true incidence is not 
known. The management of these fistulas also varies and will depend on the underlying 
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pathology. The options for management include conservative, allow the fistula to heal 
spontaneously, radiological by embolisation of the fistula tract (Hatzidakis et al) or surgical. 
5. Transvenous liver biopsy 
Transvenous liver biopsy can be undertaken via the femoral or the more commonly 
described transjugular route. It was first described by Dotter in 1964(Dotter 1964) but the 
first major series was reported by Rosch et al in 1973(Rosch, Lakin, Antonovic and Dotter 
1973). The transvenous route was introduced as an alternative to the percutaneous route 
when there are concerns about coagulopathy or significant ascites and in those with 
morbid obesity(Rockey, et al. 2009). The transjugular route has the added advantage of 
being able to measure the hepatic venous wedge pressure where necessary. The basic 
principle of the procedure is the same for both techniques. The procedure is usually 
performed by a radiologist under fluoroscopic guidance. The inferior vena cava(IVC) is 
cannulated and via this one of the hepatic veins (usually the right) is entered and a biopsy 
is taken from within the liver. The technical failure rate is reported to be 3.2% 
(Kalambokis, et al. 2007).  
The reported complication for the transjugular is as high as 20% (Grant, et al. 1999) with  
major complications occurring between 1.3 to 2.7% (Gamble, Colapinto, Stronell, Colman 
and Blendis 1985, McAfee, Keeffe, Lee and Rosch 1992). However, the most recent review of 
the literature reports a complication rate of 6.7% in adult series, comparable to complication 
rates reported in other series(Thampanitchawong, et al. 1999). The complications were 
described as both liver puncture related and non-liver puncture related and the incidence 
for both were similar. The non-liver puncture related complications are associated with the 
process of cannulating the jugular or hepatic vein or technical failure. In their retrospective 
study Soyer et al suggests that the complications associated with cannulation of the jugular 
vein can be minimized by the use of ultrasonic guidance(Soyer, Fargeaudou, Boudiaf and 
Rymer 2008). These include skin haematoma, pneumothorax, Horner’s syndrome, 
dysphonia, cholangitis and cardiac arrhythmias. One particular risk associated with this 
route is perforation of the liver capsule and intraperitoneal haemorrhage(McAfee, et al. 
1992). Even if the procedure was attempted via the femoral route capsular perforation was 
still a noted complication(Khosa, et al. 2003). Khosa suggested that this complication could 
be avoided if biopsies were taken within a central area of the liver and biplane fluoroscopy 
was used. The same would probably hold true for the transjugular route. In addition, 
Papatheodoridis et al suggested that capsular penetration was more frequent with the 
Menghini needle as a result of difficulty in controlling the depth of penetration 
(Papatheodoridis, Patch, Watkinson, Tibballs and Burroughs 1999). In their series capsular 
penetration only resulted in minor complications. The mortality rate is about 0.09% and like 
percutaneous liver biopsy was due to haemorrhage. In contrast, some deaths with 
transjugular biopsy were also related to ventricular arrhythmias as a result of manipulation 
of the catheter through the right atria and ventricle.  
One of the few comparative studies between transjugular and percutaneous biopsy was 
reported in 1994 by Hong-Chaing Meng et al. In this study the complication rate for the 
transjugular route was 7% and 9% for the percutaneous route suggesting that transjugular 
biopsy was at least as safe as percutaneous liver biopsy and re-affirmed the idea that it is a 
safe alternative in patients in whom percutaneous biopsy is contra-indicated. Interestingly, 
Atar et al reported a comparative study of plugged percutaneous liver biopsy and 
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transjugular biopsy and found no difference in major complications in either group(Atar, et 
al. 2010). They suggested that the plugged percutaneous biopsy technique should be used 
instead of the transjugular route when available. 
The use of the transvenous route for liver biopsy is well established. However, this 
technique is only practiced in a few centres mainly by radiologists or hepatologists with 
significant experience in the technique.  The indications for this procedure is restricted and 
as yet the percutaneous route is still the procedure of choice as it is simpler,  requires less 
specialized equipment and is therefore cheaper.    
6. Laparoscopic liver biopsy 
Laparoscopic liver biopsy is a well established method. It is usually undertaken when liver 
lesions are found incidentally during laparoscopy for diagnostic or staging purposes. In 
addition, staging of patients with cirrhosis and hepatocellular carcinoma who are being 
considered for resection can have a biopsy of the future liver remnant. Laparoscopic liver 
biopsy had the added advantage of direct view of the liver which reduces sampling errors 
and bleeding after biopsy allowing better control(Denzer, et al. 2007). This is supported by 
Nord et al who reported a significant decrease in sampling errors of laparoscopic biopsy 
compared to the percutaneous route in cirrhotic patients(Tobkes and Nord 1995).   
The risks of laparoscopic liver biopsy can be divided into the risks of any laparoscopic 
procedure and the risks of liver biopsy. Beckmann et al did a comparative study with 
laparoscopic, transjugular and percutaneous liver biopsy. They found that the complication 
rate was similar for all groups (2.7%, 2.9% and 3% respectively)(Beckmann, et al. 2009). 
However, in their study the transjugular route had a low success rate and they suggested 
that the laparoscopic route as an alternative especially in patients with severe coagulopathy 
(Denzer, Helmreich-Becker, Galle and Lohse 2003). The only randomized study comparing 
laparoscopic with percutaneous biopsy was reported by Denzer et al(Denzer, et al. 2007). 
This study was undertaken in cirrhotics but found a slightly higher but not significant 
difference in total complication rate between the groups (8.8% vs 5.8%).  
The main risks that we divulge to our patients specific to any laparoscopic procedure are 
bowel or aortic/inferior vena cava perforation, bleeding, post-operative shoulder tip pain 
and port-site pain and hernias. Specifically for laparoscopic liver biopsy our unit informs 
patients of the risk of bleeding or biliary leak. As a general rule we do not undertake 
laparoscopic biopsies of possible malignant lesions unless we know that the tumour is 
inoperable and a histological diagnosis is needed prior to starting chemotherapy.  
7. Conclusion 
The role of liver biopsy in the investigation of liver disease has changed over time. This is 
due to the advances in other non-invasive imaging techniques providing adequate 
information for diagnosis. It is still however a very important investigative tool in certain 
circumstances. These indications have been laid out in the American Association for the 
study of Liver Disease and the British Society of Gastroenterology. It is mainly carried out 
under image guidance although some centres still practice blind biopsies. Importantly, it is 
not without its risks and complications that both physicians and surgeons should be aware 
of. The role of bleeding parameters and other adopted protocols may not necessarily be 
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rooted in good quality evidence and there is scope for well designed randomized trials in 
certain aspects of this procedure. Finally, any patient discovered to have a lesion  in the liver 
either from radiological investigation or during surgery should be referred to a specialist 
hepato-biliary unit for further evaluation. 
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